33 results
AACE/ACE 2018 Glycemic Control Algorithm

#AACE #2018 #Glycemic #Diabetes #DM2 #Control #Medication #Algorithm #Endocrinology #PrimaryCare #Management
AACE/ACE 2018 Glycemic ... #AACE #2018 #Glycemic ... #Diabetes #DM2 ... Medication #Algorithm #Endocrinology
A1C and eAG
~
*For Educational Purposes Only*

#Diabetes #T2D #DM2 #Table #PrimaryCare #Endocrinology #BloodGlucose #A1C
Purposes Only* #Diabetes ... #T2D #DM2 #Table ... #PrimaryCare #Endocrinology
Profiles of Antidiabetic Medications - AACE 2018 

#Antidiabetic #Medications #Profiles #SideEffects #Table #DecisionAid #Orals #DM2 #Diabetes
DecisionAid #Orals #DM2 ... #Diabetes #Endocrinology
Diabetes Medication Prescribing Algorithm

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/featured

#Diabetes #Medications #Prescribing #Algorithm #management
Diabetes Medication ... EricsMedicalLectures/featured #Diabetes ... Algorithm #management #endocrinology ... #dm2
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Diabetes Type 2 ... ASCVD or CKD #Diabetes ... #DM2 #Type2 #Medication ... Management #Algorithm #endocrinology
Summary and links to five landmark trials of intensive control vs standard therapy in DM2:

 UKPDS
standard therapy in DM2 ... VisualAbstract #Endocrinology ... #PrimaryCare #Diabetes ... #DM2 #Type2 #Landmark
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
mL/minute/1.73 m2 ... candidiasis) • Euglycemic ... diabetic ketoacidosis ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... EricsMedicalLectures/featured #diabetes ... comparison #management #endocrinology ... #dm2
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
mL/minute/1.73 rm2 ... mL/minute/1.73 m2 ... Pharmacology #Summary #DM2 ... #diabetes #endocrinology
Stages in the Development of Diabetes Type 1

#Diabetes #Type1 #TypeI #DM1 #Stages #Development #Pathophysiology #Timeline #Diagnosis
Development of Diabetes ... Type 1 #Diabetes ... #Type1 #TypeI #DM1 ... Timeline #Diagnosis #Endocrinology